Apogem Capital’s SkinHealth Systems SKIN Stock Holding History

Apogem Capital’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-31,343	Closed	-$370K	–	105
2022 Q3	$370K	Buy	31,343 +8,100	+35%	+$102K	0.37%	88
2022 Q2	$299K	Hold	23,243	–	–	0.27%	111
2022 Q1	$392K	Buy	23,243 +5,435	+31%	+$89.7K	0.27%	109
2021 Q4	$430K	Buy	17,808 +3,746	+27%	+$96.5K	0.28%	109
2021 Q3	$365K	Buy	+14,062	New	+$309K	0.23%	134

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Apogem Capital's SKIN Position: Q4 2022 in Review

Apogem Capital sold out of SkinHealth Systems (SKIN) in Q4 2022, closing a stake of 31,343 shares — an estimated $370K sold.

Apogem Capital first reported a position in SKIN in Q3 2021 and held it in 5 quarters. The position peaked at $430K in Q4 2021. 158 funds tracked by Wall St. Rank hold SKIN as of Q4 2022.

Apogem Capital reported no remaining SkinHealth Systems position as of Q4 2022 after selling out during the quarter.
Apogem Capital sold 31,343 SkinHealth Systems shares in Q4 2022, an estimated $370K.
Apogem Capital first reported a position in SkinHealth Systems in Q3 2021 and held it in 5 quarters.
Apogem Capital's SkinHealth Systems position peaked at $430K in Q4 2021.
158 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.